ATE509915T1 - Antibakterielle chinolinderivate - Google Patents

Antibakterielle chinolinderivate

Info

Publication number
ATE509915T1
ATE509915T1 AT07847814T AT07847814T ATE509915T1 AT E509915 T1 ATE509915 T1 AT E509915T1 AT 07847814 T AT07847814 T AT 07847814T AT 07847814 T AT07847814 T AT 07847814T AT E509915 T1 ATE509915 T1 AT E509915T1
Authority
AT
Austria
Prior art keywords
quinoline derivatives
antibacterial quinoline
antibacterial
derivatives
quinoline
Prior art date
Application number
AT07847814T
Other languages
English (en)
Inventor
Jerome Emile Georges Guillemont
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE509915T1 publication Critical patent/ATE509915T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07847814T 2006-12-06 2007-12-04 Antibakterielle chinolinderivate ATE509915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125529 2006-12-06
PCT/EP2007/063316 WO2008068270A1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
ATE509915T1 true ATE509915T1 (de) 2011-06-15

Family

ID=38124123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07847814T ATE509915T1 (de) 2006-12-06 2007-12-04 Antibakterielle chinolinderivate

Country Status (29)

Country Link
US (1) US20110166179A1 (de)
EP (1) EP2099759B1 (de)
JP (1) JP5356246B2 (de)
KR (1) KR101526175B1 (de)
CN (1) CN101553471B (de)
AR (1) AR064152A1 (de)
AT (1) ATE509915T1 (de)
AU (1) AU2007328890B2 (de)
BR (1) BRPI0720133A2 (de)
CA (1) CA2669829C (de)
CL (1) CL2007003517A1 (de)
CY (1) CY1112230T1 (de)
DK (1) DK2099759T3 (de)
ES (1) ES2366062T3 (de)
HK (1) HK1137431A1 (de)
HR (1) HRP20110540T1 (de)
IL (1) IL199084A0 (de)
JO (1) JO2725B1 (de)
ME (1) ME01245B (de)
MX (1) MX2009005981A (de)
NO (1) NO342774B1 (de)
NZ (1) NZ577069A (de)
PL (1) PL2099759T3 (de)
PT (1) PT2099759E (de)
RS (1) RS51848B (de)
RU (1) RU2439058C2 (de)
SI (1) SI2099759T1 (de)
TW (1) TWI487525B (de)
WO (1) WO2008068270A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2786089C (en) * 2010-01-04 2014-04-15 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and agricultural fungicide
AR086411A1 (es) 2011-05-20 2013-12-11 Nippon Soda Co Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria
RU2486175C2 (ru) * 2011-09-12 2013-06-27 Закрытое Акционерное Общество "Фарм-Синтез" Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений
EA038350B1 (ru) * 2012-04-27 2021-08-12 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
ES2576491T3 (es) * 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
CN105232540A (zh) * 2015-09-29 2016-01-13 王洪燕 一种治疗烧伤后感染的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL222801B1 (pl) * 2002-07-25 2016-09-30 Janssen Pharmaceutica Nv Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
PT1711181E (pt) * 2004-01-23 2009-12-29 Janssen Pharmaceutica Nv Derivados quinolina e sua utilização como inibidores micobacterianos
EP1753427B1 (de) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Also Published As

Publication number Publication date
WO2008068270A1 (en) 2008-06-12
TW200845986A (en) 2008-12-01
HRP20110540T1 (hr) 2011-08-31
EP2099759A1 (de) 2009-09-16
AU2007328890B2 (en) 2013-03-14
NO342774B1 (no) 2018-08-06
US20110166179A1 (en) 2011-07-07
AU2007328890A1 (en) 2008-06-12
JP5356246B2 (ja) 2013-12-04
CN101553471A (zh) 2009-10-07
TWI487525B (zh) 2015-06-11
NZ577069A (en) 2011-09-30
KR20090086611A (ko) 2009-08-13
HK1137431A1 (en) 2010-07-30
EP2099759B1 (de) 2011-05-18
ES2366062T3 (es) 2011-10-14
JP2010511671A (ja) 2010-04-15
NO20092547L (no) 2009-08-24
PL2099759T3 (pl) 2011-09-30
JO2725B1 (en) 2013-09-15
AR064152A1 (es) 2009-03-18
CL2007003517A1 (es) 2008-07-11
PT2099759E (pt) 2011-07-27
MX2009005981A (es) 2009-06-16
RU2439058C2 (ru) 2012-01-10
SI2099759T1 (sl) 2011-09-30
CA2669829C (en) 2016-08-30
CN101553471B (zh) 2013-04-03
DK2099759T3 (da) 2011-08-15
KR101526175B1 (ko) 2015-06-05
IL199084A0 (en) 2010-03-28
RS51848B (en) 2012-02-29
ME01245B (me) 2013-06-20
CY1112230T1 (el) 2015-12-09
RU2009125520A (ru) 2011-01-20
CA2669829A1 (en) 2008-06-12
BRPI0720133A2 (pt) 2014-02-04

Similar Documents

Publication Publication Date Title
HK1208437A1 (en) Antibacterial quinoline derivatives
ATE467619T1 (de) Antibakterielle chinolinderivate
IL241548B (en) Antibacterial quinoline derivatives
DK2099759T3 (da) Antibakterielle chinolinderivater
DK2086941T3 (da) Antibakterielle quinolinderivater
DK2099761T3 (da) Antibakterielle quinolinderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2099759

Country of ref document: EP